Yassin-Kassab, Abdulkader
Chatterjee, Suman
Khan, Nayel
Wang, Nathaniel
Sandulache, Vlad C.
Huang, Eric H-B.
Burns, Timothy F.
Duvvuri, Umamaheswar
Funding for this research was provided by:
U.S. Department of Veterans Affairs (IO1-002345)
National Institutes of Health (RO1-DE028343)
PNC Foundation
Eye and Ear Foundation of Pittsburgh
Article History
Received: 14 August 2023
Accepted: 17 January 2024
First Online: 19 February 2024
Declarations
:
: The experimental protocols were approved by the University of Pittsburgh Institutional Animal Care and Use Committee and Institutional Biosafety Committee. This study did not involve the use of human participants or data. This study is reported in accordance with ARRIVE guidelines.
: Not applicable.
: T.B. has serves on a DSMB for Lantern Pharma. He has served on scientific advisory boards for Janssen Scientific Affairs, LLC, Jazz Pharmaceuticals Inc, Blueprint Medicines Corporation (BPMC), Emd Serono Inc, and Mirati Therapeutics, Inc. He has served as a speaker for Amgen Mexico. Remaining authors have no competing interests.